On August 9, Independence Blue Cross and Blue Cross Blue Shield of Michigan announced their alignment
Q: Who bought AmeriHealth Mercy?
A: Independence Blue Cross (IBC) and Blue Cross Blue Shield of Michigan (BCBSM) are now co-owners of AmeriHealth Mercy, with IBC owning 60% and BCBSM owning 40%.
Q: Who initially had ownership of AmeriHealth Mercy?
Q: What will happen with Mercy Health Plan's interest in Amerihealth Mercy?
A: Mercy Health Plan will be paid $170 million for its 50% ownership interest. BCBSM will acquire a minority interest in AmeriHealth Mercy. Furthermore, the Mercy Health Foundation will receive a series of contributions over a period of seven years.
Q: What appeal does AmeriHealth Mercy and this partnership create?
A: AmeriHealth Mercy has operational and care capabilities and is one of the country's largest Medicaid companies. The partnership investment will help the Blues establish a national presence in the Medicaid market. It also can help pioneer new ways of doing business that will enhance the health and wellness of the people and communities served.
Q: What additional services and benefits would this partnership produce?
A: AmeriHealth Mercy currently offers pharmacy benefits management and behavioral healthcare to 3.2 million Medicaid, Medicare and SCHIP beneficiaries in 11 states. The partnership will allow AmeriHealth Mercy to become better positioned to offer turnkey, cost-effective, comprehensive Medicaid managed care coverage and services nationwide.
Q: What is Medicaid managed care?
A: It is designed to provide quality health care at a lower cost than fee-for-service Medicaid. Due to current budget distress in the government, many states may turn to Medicaid managed care.
Q: Who is the executive at IBC?
A: In 2010, Daniel J Hilferty transitioned to IBC president and CEO after serving at AmeriHealth Mercy for 13 years in the same capacity.
Q: Who is the executive at BCBSM?
A: BCBSM's president and CEO is Daniel J Leopp
Q: Who is the executive at AmeriHealth Mercy?
A: Michael A Rashid is president and CEO.
Muthiah “Muthu” Vaduganathan Discusses the Role of SGLT2 Inhibitors in Heart Failure Treatment
March 27th 2024Editors of Managed Healthcare Executive spoke with Muthiah “Muthu” Vaduganathan MD, MPH, consultant cardiologist at Brigham and Women's Hospital and a member of faculty at Harvard Medical School, about the evolving treatment landscape for heart failure, emphasizing the use of SGLT2 inhibitors alongside other foundational therapies.
Read More
In this second part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein spoke with CeCi Connolly and Margaret "Meg" Murray about Medicare Advantage utilization and challenges, highlighting proposed CMS payment cuts and prior authorization issues.
Listen
With aging populations, osteoporosis rates are set to increase, and researchers are looking for the next innovative drug to help prevent or manage the bone disease as there is currently no drug that completely does so effectively, according to a recent study published in Advanced Science.
Read More
In this first part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein kicks off our new podcast series "DC Roundtable," with guests Margaret "Meg" Murray, CEO of the Association of Community Affiliated Plans, and member of MHE's Editorial Advisory Board, and CeCi Connolly, president and CEO of the Alliance of Community Health Plans, for a discussion on healthcare policy issues.
Listen
2024 Emerging Leaders in Healthcare — Submit For a Chance to Be Featured in MHE's August Issue
March 26th 2024MHE Editors are seeking diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests. Eligible candidates are early or mid-career leaders with less than 10 years of experience. Award winners will enjoy complimentary passes to the PBMI Annual National Meeting in Orlando, Florida, from Sept. 4-6. Additional perks include a feature in our August issue, a subscription to MHE and more!
Read More